Detalhe da pesquisa
1.
Alzheimer's Targeted Treatments: Focus on Amyloid and Inflammation.
J Neurosci
; 43(47): 7894-7898, 2023 11 22.
Artigo
em Inglês
| MEDLINE | ID: mdl-37968119
2.
Plasma pTau217 predicts continuous brain amyloid levels in preclinical and early Alzheimer's disease.
Alzheimers Dement
; 2024 Jun 28.
Artigo
em Inglês
| MEDLINE | ID: mdl-38940656
3.
Lewy body dementia: Overcoming barriers and identifying solutions.
Alzheimers Dement
; 20(3): 2298-2308, 2024 Mar.
Artigo
em Inglês
| MEDLINE | ID: mdl-38265159
4.
The AHEAD 3-45 Study: Design of a prevention trial for Alzheimer's disease.
Alzheimers Dement
; 19(4): 1227-1233, 2023 04.
Artigo
em Inglês
| MEDLINE | ID: mdl-35971310
5.
New directions in clinical trials for frontotemporal lobar degeneration: Methods and outcome measures.
Alzheimers Dement
; 16(1): 131-143, 2020 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-31668596
6.
Development and validation of an algorithm for identifying urinary retention in a cohort of patients with epilepsy in a large US administrative claims database.
Pharmacoepidemiol Drug Saf
; 25(4): 413-21, 2016 Apr.
Artigo
em Inglês
| MEDLINE | ID: mdl-26889887
7.
Risk of cancer in patients exposed to gabapentin in two electronic medical record systems.
Pharmacoepidemiol Drug Saf
; 21(2): 214-25, 2012 Feb.
Artigo
em Inglês
| MEDLINE | ID: mdl-22144034
8.
Background incidence of liver chemistry abnormalities in pediatric clinical trials for conditions with and without underlying liver disease.
Regul Toxicol Pharmacol
; 62(2): 329-35, 2012 Mar.
Artigo
em Inglês
| MEDLINE | ID: mdl-22057095
9.
Modeling Alzheimer's disease progression using the disease system analysis approach.
Alzheimers Dement
; 8(1): 39-50, 2012 Jan.
Artigo
em Inglês
| MEDLINE | ID: mdl-21782528
10.
The epidemiology of Alzheimer's disease: laying the foundation for drug design, conduct, and analysis of clinical trials.
Alzheimers Dement
; 8(3): 237-42, 2012 May.
Artigo
em Inglês
| MEDLINE | ID: mdl-22546356
11.
Risk factors for antiepileptic drug regimen change in patients with newly diagnosed epilepsy.
Epilepsy Behav
; 21(2): 168-72, 2011 Jun.
Artigo
em Inglês
| MEDLINE | ID: mdl-21531633
12.
Lewy Body Dementia Association's Industry Advisory Council: proceedings of the second annual meeting.
Alzheimers Res Ther
; 13(1): 124, 2021 07 08.
Artigo
em Inglês
| MEDLINE | ID: mdl-34238345
13.
An exploration of cognitive subgroups in Alzheimer's disease.
J Int Neuropsychol Soc
; 16(2): 233-43, 2010 Mar.
Artigo
em Inglês
| MEDLINE | ID: mdl-19958568
14.
Effects of simvastatin on cholesterol metabolism and Alzheimer disease biomarkers.
Alzheimer Dis Assoc Disord
; 24(3): 220-6, 2010.
Artigo
em Inglês
| MEDLINE | ID: mdl-20473136
15.
Performance characteristics of plasma amyloid-beta 40 and 42 assays.
J Alzheimers Dis
; 16(2): 277-85, 2009.
Artigo
em Inglês
| MEDLINE | ID: mdl-19221417
16.
Rapid progression from mild cognitive impairment to Alzheimer's disease in subjects with elevated levels of tau in cerebrospinal fluid and the APOE epsilon4/epsilon4 genotype.
Dement Geriatr Cogn Disord
; 27(5): 458-64, 2009.
Artigo
em Inglês
| MEDLINE | ID: mdl-19420940
17.
Plasma urate and progression of mild cognitive impairment.
Neurodegener Dis
; 6(1-2): 23-8, 2009.
Artigo
em Inglês
| MEDLINE | ID: mdl-19066433
18.
Severity dependent distribution of impairments in PSP and CBS: Interactive visualizations.
Parkinsonism Relat Disord
; 60: 138-145, 2019 03.
Artigo
em Inglês
| MEDLINE | ID: mdl-30201421
19.
Plasma beta amyloid and the risk of Alzheimer disease and dementia in elderly men: a prospective, population-based cohort study.
Arch Neurol
; 65(2): 256-63, 2008 Feb.
Artigo
em Inglês
| MEDLINE | ID: mdl-18268197
20.
Candidate single-nucleotide polymorphisms from a genomewide association study of Alzheimer disease.
Arch Neurol
; 65(1): 45-53, 2008 Jan.
Artigo
em Inglês
| MEDLINE | ID: mdl-17998437